Forus

Therapeutics

is a Canadian biopharmaceutical
company dedicated to advancing
differentiated, novel medicines
for hematologic malignancies
and other forms of cancer.

About Forus

Leadership

Values

Latest News

WELCOME, Lisa Kolomaya

FORUS Therapeutics is thrilled to welcome Lisa Kolomaya as Therapeutic Area Manager, Hematology/Oncology, AB/SK. Lisa is a results-driven life sciences professional with extensive expertise in both oncology and hematology. Guided by a strategic mindset and passion for...

WELCOME, Erin Webb

FORUS Therapeutics is thrilled to welcome Erin Webb as Therapeutic Area Manager, Hematology/Oncology, SW ON. Erin began her career as a physician assistant in the US, caring for patients with both benign and malignant hematologic conditions as well as managing...

US-authorized BESREMi® Now Available

US-authorized BESREMi® Now Available

FORUS Therapeutics is pleased to announce that US-authorized BESREMi® (ropeginterferon alfa-2b-njft), is now available in Canada, via Exceptional Importation. Please note, BESREMi®’s active ingredient, ropeginterferon alfa-2b-njft, has not been reviewed under Health...

Contact Us

Mailing Address:

FORUS Therapeutics Inc.
200 North Service Road West, Suite 129
Oakville, Ontario, L6M 2Y1

Phone: 1-877-359-9595
Fax: 1-877-359-9590

Patient Support:

Phone: 1-833-4YOUPSP (1-833-496-8777)
Fax: 1-833-4YOUFAX (1-833-496-8329)

Product Support:

Phone: 1-866-542-7500
Fax: 1-866-542-1100

Do not use this form to report adverse events. Adverse events can be reported at 1-866-542-7500.